Related Experiment Video
Updated: May 6, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Mitochondrial DNA variations associated with hypertrophic cardiomyopathy
Periyasamy Govindaraj1, Nahid Akhtar Khan2, Bindu Rani3
1Department of Biomedical Science, School of Basic Medical Sciences, Bharathidasan University, Tiruchirappalli, India.
Insights
Mitochondrial DNA (mtDNA) variations, including novel mutations, were identified in Indian patients with hypertrophic cardiomyopathy (HCM). However, mitochondrial haplogroups were not associated with HCM in this study.
Area of Science:
- Genetics
- Cardiology
- Mitochondrial Biology
Background:
- Hypertrophic cardiomyopathy (HCM) is a genetic heart muscle disease characterized by left ventricular hypertrophy.
- Mitochondrial DNA (mtDNA) mutations and haplogroups are implicated in various diseases.
- Understanding genetic factors in HCM is crucial for diagnosis and treatment.
Purpose of the Study:
- To investigate the role of mitochondrial DNA variations and haplogroups in the phenotype of hypertrophic cardiomyopathy among Indian patients.
- To identify novel mtDNA mutations associated with HCM.
- To explore the potential impact of these mutations on cardiac energy production.
Main Methods:
- Complete mitochondrial DNA (mtDNA) sequencing was performed on 114 clinically characterized HCM patients.
- Analysis included identification of novel variations, disease-associated mutations, and private mutations.
- In silico predictions were used to assess the pathogenicity of identified mutations.
Main Results:
- The study identified 28 novel mtDNA variations, 25 disease-associated mutations, and 50 private mutations.
- Approximately 11.40% of HCM patients carried novel non-synonymous and/or MT-tRNA variations.
- Two specific mutations (m.4797C>M and m.8728T>Y) were found in a heteroplasmic state, with in silico analysis suggesting potential pathogenicity affecting energy production.
- No association was found between mitochondrial haplogroups and HCM in this cohort.
Conclusions:
- Novel mitochondrial DNA variations, including potentially pathogenic mutations, are present in Indian patients with hypertrophic cardiomyopathy.
- These variations may contribute to HCM pathogenesis by affecting cardiac energy metabolism.
- Mitochondrial haplogroups do not appear to be associated with HCM in the studied Indian population.
Abstract:
Hypertrophic cardiomyopathy (HCM) is a primary disorder, characterized by unexplained hypertrophy of the left ventricle that frequently involved in the inter-ventricular septum. Mitochondrial DNA (mtDNA) mutations and haplogroups have been found to be associated with several diseases. Therefore, in the present study, we have sequenced the complete mtDNA of 114 clinically well-characterized HCM patients to look for the role of mtDNA variations and haplogroups in HCM phenotype among Indian patients. Complete mtDNA analysis revealed 28 novel variations, 25 disease-associated and 50 private mutations. We found 13 (11.40%) HCM patients having novel non-synonymous and/or MT-tRNA variations, of which two (m.4797C>M and m.8728T>Y) were in heteroplasmic condition. In silico prediction showed that a few mutations are pathogenic, which may affect the energy production in the heart. Unlike some of the other studies, we did not find association of mitochondrial haplogroup with HCM.
More Related Videos
07:24Genotyping Single Nucleotide Polymorphisms in the Mitochondrial Genome by Pyrosequencing
Published on: February 10, 2023
06:53Visualization of Mitochondrial Respiratory Function using Cytochrome C Oxidase / Succinate Dehydrogenase COX/SDH Double-labeling Histochemistry
Published on: November 23, 2011
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Animal Mitochondrial Genetics
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy II: Dilated Cardiomyopathy
The Inner Mitochondrial Membrane
Cardiomyopathy V: Interprofessional Care